Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine
2. Cl 71,563
3. Cl-71,563
4. Cl71,563
5. Cloxazepine
6. Hydrochloride, Loxapine
7. Loxapine
8. Loxapine Monohydrochloride
9. Loxapine Succinate
10. Loxapinsuccinate
11. Loxipine Maleate
12. Loxipine Succinate
13. Loxitane
14. Maleate, Loxipine
15. Oxilapine
16. Succinate, Loxapine
1. Loxapine Hcl
2. Loxitane C
3. Loxitane Im
4. 54810-23-0
5. Loxapine (hydrochloride)
6. 376myl4mal
7. Desconex (tn)
8. Loxapine Monohydrochloride
9. Unii-376myl4mal
10. 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine Monohydrochloride
11. Schembl41625
12. Chembl1201060
13. Dtxsid70203304
14. Hy-17390b
15. Loxapine Hydrochloride [vandf]
16. Loxapine Hydrochloride [mart.]
17. Loxapine Hydrochloride [who-dd]
18. Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-, Monohydrochloride
19. Loxapine Hydrochloride [orange Book]
20. Cs-0031021
21. Ft-0670868
22. D08148
23. Q27256644
24. 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;hydrochloride
| Molecular Weight | 364.3 g/mol |
|---|---|
| Molecular Formula | C18H19Cl2N3O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 363.0905176 g/mol |
| Monoisotopic Mass | 363.0905176 g/mol |
| Topological Polar Surface Area | 28.1 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 450 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Loxapine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loxapine Hydrochloride, including repackagers and relabelers. The FDA regulates Loxapine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loxapine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Loxapine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Loxapine Hydrochloride supplier is an individual or a company that provides Loxapine Hydrochloride active pharmaceutical ingredient (API) or Loxapine Hydrochloride finished formulations upon request. The Loxapine Hydrochloride suppliers may include Loxapine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Loxapine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Loxapine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Loxapine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Loxapine Hydrochloride GMP manufacturer or Loxapine Hydrochloride GMP API supplier for your needs.
A Loxapine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Loxapine Hydrochloride's compliance with Loxapine Hydrochloride specifications and serves as a tool for batch-level quality control.
Loxapine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Loxapine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Loxapine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Loxapine Hydrochloride EP), Loxapine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Loxapine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
